NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA) announced today that its Cogenics® division, the global leader in outsourced genomics services, has been recognized by Eli Lilly and Company for offering value-based genomics solutions that enable Lilly to create and sustain a competitive advantage.
